PMID: 9541081Apr 16, 1998Paper

Faecal occult blood screening for colorectal cancer: is it cost-effective?

Health Economics
D K WhynesJ D Hardcastle

Abstract

Recently published evidence from two large-scale clinical trials conducted in England and in Denmark suggests that faecal occult blood screening for colorectal cancer significantly reduces mortality. However, before screening can be advocated as part of national health policy, its cost-effectiveness must be demonstrated. The English screening trial has been the subject of a detailed economic evaluation over the past 10 years In this paper, cost-effectiveness estimates of screening are presented, based on cost and outcome data combined in a mathematical model developed from the trial's clinical findings The estimates of cost per quality-adjusted life-year gained from colorectal cancer screening show the procedure to be of similar cost-effectiveness to breast cancer screening in the short term. Over the longer term, however, the estimates for colorectal cancer screening appear superior.

Citations

Aug 3, 2010·International Journal of Colorectal Disease·Göran EkelundSophia Zackrisson
Dec 17, 2009·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Panos Kanavos, Willemien Schurer
Aug 1, 2007·Journal of General Internal Medicine·Stephen G HenryRobert S Dittus
Jul 5, 2003·Journal of Health Economics·David K WhynesJane L Wolstenholme
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LoeveJ D Habbema
Sep 11, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E FrewD K Whynes
Dec 28, 1999·Critical Reviews in Oncology/hematology·D Gyrd-Hansen
Apr 4, 2002·Journal of General Internal Medicine·Joel F WallaceJoshua J Ofman
Oct 17, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PapamichaelUNKNOWN SIOG
Jun 3, 2011·Epidemiologic Reviews·Iris Lansdorp-VogelaarHermann Brenner
Jun 27, 2000·Australian and New Zealand Journal of Medicine·A J Stanley, D J St John
May 21, 2005·Australia and New Zealand Health Policy·Nicholas GravesBeth Newman
Aug 12, 2009·PharmacoEconomics·Natasha K StoutG Scott Gazelle
Feb 26, 2014·Global Health Action·Neha BaturaJolene Skordis-Worrall
May 29, 2008·European Journal of Endocrinology·Chrysoula DosiouLawrence M Crapo
Mar 15, 2006·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Greg MearsJ Michael Dean
Feb 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·David K Whynes
Sep 14, 2010·Best Practice & Research. Clinical Gastroenterology·Marjolein van BallegooijenAnn G Zauber
Feb 15, 2005·Australian and New Zealand Journal of Public Health·Christine A StoneJames St John
Dec 1, 2001·Expert Review of Pharmacoeconomics & Outcomes Research·R Crott
Oct 23, 2009·International Journal of Technology Assessment in Health Care·Paul TappendenHazel Pilgrim
Dec 22, 2004·International Journal of Technology Assessment in Health Care·Catherine LejeuneJean Faivre
Jan 12, 2010·International Journal of Technology Assessment in Health Care·Catherine LejeuneJean Faivre
Aug 5, 2000·The American Journal of Gastroenterology·R M NessR Dittus
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R A HirthW G Weissert
Apr 16, 2003·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Emma J FrewJane L Wolstenholme
Dec 5, 2006·Current Opinion in Cardiology·Laura S Gold, Mickey Eisenberg
Nov 30, 2000·The American Journal of Gastroenterology·J F HelmR S Sandler
Jul 12, 2008·European Journal of Gastroenterology & Hepatology·Julian Perez-PalmaVicente Medina-Arana
May 5, 2000·Radiology·G S GazelleF J Scholz
Jan 28, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C LejeuneJ Faivre
Mar 10, 2004·Journal of Medical Screening·David K Whynes, UNKNOWN Nottingham FOB Screening Trial
Jul 29, 2000·The Medical Journal of Australia·P A BamptonJ S John
Apr 12, 2001·The Medical Journal of Australia·T D BolinM G Korman
Mar 4, 2006·Gastroentérologie Clinique Et Biologique·Denis HeresbachJean-François Bretagne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.